Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Temozolomide
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(4)
+
-
Availability
Open access
(3)
+
-
Metadata Only
(1)
+
-
Faculty
Faculty of Science
(1)
+
-
Leiden University Medical Center (LUMC)
(2)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(2)
+
-
Topic
Temozolomide
(4)
+
-
Glioma
(2)
+
-
Author
Reijneveld, J.C.
(3)
+
-
Bent, M.J. van den
(2)
+
-
Coens, C.
(2)
+
-
Dirven, L.
(2)
+
-
Golfinopoulos, V.
(2)
+
-
Taphoorn, M.J.B.
(2)
+
-
Show more
Language
en
(4)
+
-
Search results
(1 - 4 of 4)
show grid
show list
save search
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first- recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatme
Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma
Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status
Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide